China Telemedicine Market

ID: MRFR/MED/43378-HCR
200 Pages
Satyendra Maurya
Last Updated: April 06, 2026
China Telemedicine Market Research Report: Size, Share, Trend Analysis By Product (Software, Hardware), By Services (Tele-Consulting, Tele-Monitoring, Tele-Education, Others), By Types (Tele-Nursing, Tele-Pharmacy, Tele-Radiology, Tele-Dermatology, Tele-Oncology, Others), By Deployment (On-Premise, Cloud-Based) and By End Users (Hospitals and Clinics, Home Care, Others) - Growth Outlook & Industry Forecast 2025 To 2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Chemicals and Materials, BY Service Type (USD Billion)
      1. 4.1.1 Real-time Consultation
      2. 4.1.2 Remote Patient Monitoring
      3. 4.1.3 Store-and-Forward Telemedicine
      4. 4.1.4 Mobile Health Applications
    2. 4.2 Chemicals and Materials, BY Technology (USD Billion)
      1. 4.2.1 Video Conferencing
      2. 4.2.2 Mobile Health Applications
      3. 4.2.3 Web-based Platforms
      4. 4.2.4 Wearable Devices
    3. 4.3 Chemicals and Materials, BY End-user (USD Billion)
      1. 4.3.1 Hospitals
      2. 4.3.2 Private Practices
      3. 4.3.3 Home Care Settings
      4. 4.3.4 Healthcare Institutions
    4. 4.4 Chemicals and Materials, BY Specialty (USD Billion)
      1. 4.4.1 Emergency Services
      2. 4.4.2 Psychiatry
      3. 4.4.3 Dermatology
      4. 4.4.4 Pediatrics
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Chemicals and Materials
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Chemicals and Materials
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Teladoc Health (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Amwell (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 MDLIVE (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Doxy.me (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Doctor on Demand (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 HealthTap (US)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Lemonaid Health (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 PlushCare (US)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 CHINA MARKET ANALYSIS BY SERVICE TYPE
    3. 6.3 CHINA MARKET ANALYSIS BY TECHNOLOGY
    4. 6.4 CHINA MARKET ANALYSIS BY END-USER
    5. 6.5 CHINA MARKET ANALYSIS BY SPECIALTY
    6. 6.6 KEY BUYING CRITERIA OF CHEMICALS AND MATERIALS
    7. 6.7 RESEARCH PROCESS OF MRFR
    8. 6.8 DRO ANALYSIS OF CHEMICALS AND MATERIALS
    9. 6.9 DRIVERS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
    10. 6.10 RESTRAINTS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
    11. 6.11 SUPPLY / VALUE CHAIN: CHEMICALS AND MATERIALS
    12. 6.12 CHEMICALS AND MATERIALS, BY SERVICE TYPE, 2024 (% SHARE)
    13. 6.13 CHEMICALS AND MATERIALS, BY SERVICE TYPE, 2024 TO 2035 (USD Billion)
    14. 6.14 CHEMICALS AND MATERIALS, BY TECHNOLOGY, 2024 (% SHARE)
    15. 6.15 CHEMICALS AND MATERIALS, BY TECHNOLOGY, 2024 TO 2035 (USD Billion)
    16. 6.16 CHEMICALS AND MATERIALS, BY END-USER, 2024 (% SHARE)
    17. 6.17 CHEMICALS AND MATERIALS, BY END-USER, 2024 TO 2035 (USD Billion)
    18. 6.18 CHEMICALS AND MATERIALS, BY SPECIALTY, 2024 (% SHARE)
    19. 6.19 CHEMICALS AND MATERIALS, BY SPECIALTY, 2024 TO 2035 (USD Billion)
    20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 China MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
      2. 7.2.2 BY TECHNOLOGY, 2025-2035 (USD Billion)
      3. 7.2.3 BY END-USER, 2025-2035 (USD Billion)
      4. 7.2.4 BY SPECIALTY, 2025-2035 (USD Billion)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

China Chemicals and Materials Market Segmentation

Chemicals and Materials By Service Type (USD Billion, 2025-2035)

  • Real-time Consultation
  • Remote Patient Monitoring
  • Store-and-Forward Telemedicine
  • Mobile Health Applications

Chemicals and Materials By Technology (USD Billion, 2025-2035)

  • Video Conferencing
  • Mobile Health Applications
  • Web-based Platforms
  • Wearable Devices

Chemicals and Materials By End-user (USD Billion, 2025-2035)

  • Hospitals
  • Private Practices
  • Home Care Settings
  • Healthcare Institutions

Chemicals and Materials By Specialty (USD Billion, 2025-2035)

  • Emergency Services
  • Psychiatry
  • Dermatology
  • Pediatrics